Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
CCSD Code

CCSD code J1300 – Percutaneous liver lesion biopsy

Billable Code


Code Definition

J1300 is the CCSD code for percutaneous biopsy of lesion of liver. It covers a needle biopsy of a focal liver lesion through the skin, by core needle or fine needle aspiration, under ultrasound or CT guidance.

J1300 sits in the CCSD Abdomen chapter, in the Other Organs (Mainly Digestive) section. Histopathology is billed separately, and imaging guidance is billed on its own line where the insurer allows it.

Group
11.0.0 Abdomen (Excl. Urinary & Reproductive Organs)
Category
11.7.0 Other Organs (Mainly Digestive)
Subcategory
Procedural code, CCSD reference Fk.129
Billable
Yes
Code also known as
needle liver biopsy, core needle liver biopsy, liver lesion needle biopsy, hepatic biopsy, ultrasound-guided liver biopsy
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CCSD code J1300 covers a needle biopsy of a focal liver lesion through the skin, by core needle or fine needle aspiration.

Histopathology is always billed separately, and imaging guidance is billed on its own line only where the insurer doesn’t bundle it into J1300.

Bupa, AXA Health, Aviva and Vitality Health typically require pre-authorization. A missing authorization number is the most common reason a J1300 claim is declined.

ICD-10 codes such as R93.2, C22.x, C78.7 and K74.x establish medical necessity, and the more specific code supports the claim better.

Pabau, the practice management platform we build, stores each insurer’s J1300 fee and pre-authorization and sends the claim through Healthcode.

What is CCSD code J1300?

CCSD code J1300 is the UK private healthcare procedure code for percutaneous biopsy of lesion of liver. A practitioner passes a needle through the abdominal wall, under real-time imaging, to take tissue from a focal liver lesion. The code covers core needle biopsy, which retrieves a tissue core for histopathology, and fine needle aspiration (FNA), which yields cells for cytology.

The Clinical Coding & Schedule Development (CCSD) group maintains the procedure schedule that UK private insurers use. J1300 sits in chapter 11.0.0, Abdomen (Excl. Urinary & Reproductive Organs), within section 11.7.0, Other Organs (Mainly Digestive). Each insurer sets its own fee against the code, as the Bupa CCSD codes schedule shows.

Hepatology, gastroenterology and interventional radiology practices bill it most often. The code doesn’t distinguish between a primary liver tumor, a metastatic deposit or a lesion in chronic liver disease. Code selection turns on the approach alone. A laparoscopic, open or transjugular biopsy is billed under a different CCSD code.

What the procedure involves: Percutaneous biopsy of a liver lesion

A percutaneous liver biopsy begins before the patient reaches the procedure room. A coagulation screen (INR, platelet count and PT) confirms the patient can safely tolerate needle puncture. The British Society of Gastroenterology recommends INR and platelet thresholds before proceeding, and the procedure note must record these results.

The procedure itself runs in seven steps.

  1. Patient positioning and skin preparation at the biopsy site
  2. Real-time imaging (ultrasound or CT) to identify the target lesion and map the needle trajectory
  3. Local anesthetic injection at the planned puncture site
  4. Needle advancement under continuous imaging guidance to the lesion margin
  5. Core biopsy firing or FNA aspiration, with one or more passes as needed for an adequate specimen
  6. Immediate post-procedure imaging to confirm there’s no hemorrhage or pneumothorax
  7. At least two hours of monitored observation before discharge

The biopsy diagnoses a focal liver lesion seen on earlier ultrasound, CT or MRI, or stages a known liver cancer. It also grades chronic liver disease when noninvasive fibrosis markers are inconclusive. Typical examples are non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) and viral hepatitis. The pathology lab, not the proceduralist, bills the histopathology report on the specimen.

What J1300 includes and what it does not

Knowing the scope of CCSD code J1300 prevents the two most common claim errors. One is billing extra for services J1300 already covers. The other is missing a separate charge for services outside it.

ServiceIncluded in J1300?Notes
Needle biopsy of the liver lesionYesCore of the procedure. The code applies to both core needle and FNA approaches.
Local anesthetic administrationYesConsidered part of the procedural episode.
Immediate post-procedure monitoringYesStandard observation period after the procedure.
Ultrasound or CT imaging guidancePayer-dependentSeparately billable under most insurer schedules, but bundling rules vary. Confirm against the payer handbook before billing.
Histopathology analysis of the specimenNoBilled separately by the pathology lab under the appropriate pathology CCSD code.
Radiologist reporting fee for guidance imagesNoSeparate CCSD radiology code. The radiologist bills it when a different clinician performs the guidance.
Consultant consultation before the biopsyNoBilled under the appropriate consultation CCSD code, on the same or an earlier date.

Grouped by who bills them, those services turn one biopsy into as many as four claim lines.

Diagram of the four claim lines one CCSD J1300 percutaneous liver biopsy can generate: 1, J1300 billed by the proceduralist, covering core needle or FNA biopsy, local anesthetic and immediate monitoring; 2, imaging guidance under a CCSD radiology code, payer-dependent; 3, histopathology billed by the pathology lab, never in J1300; 4, the preceding consultation, never in J1300. The claim also needs a pre-authorization number and an ICD-10 code such as R93.2, C22.x, C78.7 or K74.x.
Only the first line is J1300 itself, and the guidance line depends on each insurer’s bundling rules. Summary drawn from the scope table in this article.

Imaging guidance: How to code it alongside J1300

Ultrasound guides the vast majority of percutaneous liver biopsies in UK private practice. CT guidance is used for deep lesions or when ultrasound gives a poor view. Whether guidance is billed separately alongside CCSD code J1300 depends on the payer, not on a universal CCSD rule.

Under most insurer schedules, real-time guidance during a percutaneous biopsy is a separately codable radiology service. The CCSD radiology chapter carries codes for ultrasound and CT guidance of interventional procedures. Some payers bundle guidance into the J1300 fee, though, and won’t pay a separate radiology line. Check the insurer’s provider handbook or the Healix fee schedule before adding a guidance code.

When guidance is billed separately, the procedure note must document three details.

  • The modality used, ultrasound or CT
  • That the guidance was real-time, not a pre-procedure image only
  • The clinician who performed the guidance, if it wasn’t the proceduralist

If one clinician performs both the guidance and the biopsy, most CCSD schedules still allow both codes. That remains payer-dependent, so check before you bill.

Choosing CCSD code J1300 correctly means knowing when a different liver code applies. The approach is the main selection criterion.

CCSD codeDescriptorWhen to use instead of J1300
J1300Percutaneous biopsy of lesion of liverNeedle biopsy through the skin, with imaging guidance and no open incision.
Separate CCSD code (look up in the schedule)Laparoscopic biopsy of liverBiopsy under laparoscopic view through a port. It is more complex than the percutaneous approach.
Separate CCSD code (look up in the schedule)Open (surgical) liver biopsyBiopsy taken during open surgery, when the abdomen is surgically opened.
Separate CCSD code (look up in the schedule)Transjugular (transvenous) liver biopsyBiopsy through the hepatic vein. It is used when coagulopathy or ascites makes the percutaneous approach unsafe.
J1400Open puncture of liverA neighboring code in the same section for an open, rather than percutaneous, liver puncture.

Laparoscopic, open and transjugular liver biopsies are billed under other CCSD codes in the abdomen chapter. Confirm the exact code against the CCSD schedule or browse the CCSD codes library before you bill. The approach descriptor is the reliable selection criterion.

If the biopsy confirms a resectable tumor, the liver resection is billed under J0310. In the US, the same needle biopsy is reported under CPT code 47000.

ICD-10 diagnosis codes that support J1300

A J1300 claim needs an ICD-10 diagnosis code that establishes medical necessity. UK private insurers use the WHO edition of ICD-10, not the US ICD-10-CM. A vague or unspecified code without clinical context in the notes is a common denial trigger. These are the codes used most often.

ICD-10 codeDescriptionClinical context for J1300
R93.2Abnormal findings on diagnostic imaging of liver and biliary tractUncharacterized focal lesion on CT or MRI that needs a tissue diagnosis.
C22.0Hepatocellular carcinomaBiopsy to confirm HCC when imaging criteria are equivocal or the payer requires tissue confirmation.
C22.9Malignant neoplasm of liver, unspecifiedPrimary liver cancer not yet classified at the time of biopsy.
C78.7Secondary malignant neoplasm of liver and intrahepatic bile ductSuspected liver metastasis from a known or suspected primary elsewhere.
K74.6Other and unspecified cirrhosis of liverHistological staging or grading of cirrhosis when noninvasive markers are inconclusive.
K76.0Fatty (change of) liver, not elsewhere classified (NAFLD)Grading of NAFLD or NASH when elastography or blood panels are indeterminate.
B18.2Chronic viral hepatitis CFibrosis staging before treatment in chronic hepatitis C.
K75.8Other specified inflammatory diseases of liverAutoimmune hepatitis or another inflammatory liver disease that needs histological confirmation.

Some payers ask for extra justification when R93.2 is used alone, without context in the referral letter or pre-procedure notes. Where cancer is suspected, C22.x or C78.7 usually supports the claim more strongly than R93.2.

Pre-authorization requirements for J1300

Most major UK private medical insurance (PMI) payers require pre-authorization before a percutaneous liver biopsy. Billing CCSD code J1300 without a valid authorization number is the most common reason a claim is declined at first review. The table summarizes each major payer’s approach. Policies change, so confirm against each provider handbook before submission.

PayerPre-auth typically required?Submission channelWhat to include
BupaYes, in most casesBupa code search portal or provider helplineReferral letter, imaging report confirming the lesion, clinical indication and the proposed J1300 code.
AXA HealthYes, typically requiredAXA provider portalSpecialist referral, imaging findings, ICD-10 diagnosis code and the planned procedure code.
AvivaYes, for diagnostic proceduresAviva fee schedule portalReferral letter, clinical justification and the planned CCSD code.
Vitality HealthYes, for interventional proceduresVitality fee finder or provider lineSpecialist letter confirming the indication, the proposed procedure and supporting imaging.

Record the authorization number in the patient record and on the invoice as soon as you receive it. Practitioners new to private work rarely met this step in the NHS, so build it into the booking routine from the start.

Pro Tip

Request pre-authorization before the patient is booked onto the procedure list, not on the day. Most UK PMI payers won’t retrospectively authorize a J1300 biopsy that has already been performed, even with a clear clinical indication. Build a pre-auth checkpoint into your booking workflow for every private liver procedure.

Documentation requirements for a valid J1300 claim

Incomplete documentation is the second most common cause of J1300 denials, after missing pre-authorization. A complete procedure note for a percutaneous liver biopsy contains these eight elements.

  • Pre-procedure imaging reference: The ultrasound, CT or MRI report that identified the lesion, cited by date and modality
  • Coagulation screen results: INR, platelet count and PT, recorded immediately before the procedure
  • Written consent: Confirmation that the risks were explained and consent was obtained, covering hemorrhage, infection, bile leak, pneumothorax and an inadequate sample
  • Needle type and gauge: For example, an 18-gauge Bard Max-Core, or a 22-gauge Chiba needle for FNA. The gauge and type confirm the biopsy approach
  • Imaging guidance modality: Whether ultrasound or CT guidance was used, and whether it was real-time throughout
  • Number of passes and specimen adequacy: How many needle passes were made, and whether the specimen looked adequate
  • Approach route: Intercostal, subcostal or other, plus the trajectory relative to the lesion
  • Immediate post-procedure status: The patient’s hemodynamic status, any immediate complications and the monitoring plan

A structured procedure note template in your digital documentation tool captures every required field before the patient leaves recovery. A note written more than 24 to 48 hours after the procedure is harder to defend if a payer requests it during a claim review.

Standardized templates also reduce audit risk when a practice writes a high volume of private procedure notes.

Pabau medical form builder showing a template library and an app preview of a patient form
Pabau’s form builder starts each procedure note from a template, so fields like needle gauge and pass count are filled in before discharge.

Common reasons J1300 claims are denied

Most J1300 denials fall into a handful of repeating causes. Fixing the root cause before resubmission is faster than disputing a denial without addressing it.

Denial reasonCorrective action
No authorization number on the claimResubmit with the authorization number, or ask the payer whether retrospective authorization is possible.
Vague or absent ICD-10 diagnosis codeReplace R93.2 or K76.9 (unspecified) with the most specific code available. Add clinical justification to the procedure note.
Imaging guidance billed when the payer bundles itRemove the guidance code from the claim, and review the payer’s current bundling policy before the next case.
Procedure note missing or incompleteProvide the complete procedure note. If elements such as needle gauge or number of passes are missing, add a dated addendum.
Claim submitted outside the timely filing windowCheck the payer’s timely filing limit, typically 60 to 180 days from the date of service. Appeal with proof of timely submission if you filed within it.
Wrong code selected (approach mismatch)Confirm the biopsy approach. If it was laparoscopic or transjugular, replace J1300 with the correct approach-specific CCSD code.

Coding J1300 for complications of percutaneous liver biopsy

Percutaneous liver biopsy has a well-documented complication profile. Clinical literature, including the BSG liver biopsy guidelines, names hemorrhage as the most common serious complication. Bile leak, hematoma and pneumothorax are the other significant risks. When a complication arises, the coding extends beyond J1300 itself.

Treat the approach below as illustrative. Verify complication codes with a qualified clinical coder or the payer’s handbook before submission, because incorrect complication coding carries compliance risk.

  • Hemorrhage requiring intervention: A separate CCSD interventional code covers hemostatic embolization or other active management. ICD-10 T81.0 (hemorrhage complicating a procedure) or K76.8 (other specified diseases of liver) may apply, depending on the clinical context
  • Hematoma not requiring active intervention: Document it in the procedure note and the observation record. No extra CCSD code typically applies unless a further procedure is performed
  • Bile leak: If it’s managed conservatively, document the finding and the management plan. If drainage is required, a separate CCSD code covers that interventional episode
  • Pneumothorax: If a chest drain is needed, a separate thoracic CCSD code covers it. Use ICD-10 J95.8 (other postprocedural respiratory disorders) for a pneumothorax caused by the biopsy. J93.x applies only to spontaneous pneumothorax

When a complication extends the episode, such as an overnight admission after hemorrhage, the admission codes and daily fees are billed separately from J1300. The biopsy’s procedure note must document the complication clearly so the extra codes stand up on audit.

Billing J1300 in practice management software

Submitting CCSD code J1300 cleanly takes a system that covers the whole workflow. That means fee schedule setup, ICD-10 attachment, authorization tracking and claim submission to the insurer. Practices running this through spreadsheets and email risk submission errors and late payment.

Pabau’s claims management software handles that workflow for UK private practices. For J1300, it runs in six steps.

  1. Fee setup: Add J1300 to the fee schedule with each insurer’s agreed fee. Pabau then raises each invoice at that insurer’s contract rate, so Bupa, AXA Health and Aviva rates apply automatically
  2. ICD-10 attachment: Link the ICD-10 code, such as R93.2, C22.x, C78.7 or K74.x, to the patient episode before invoicing
  3. Authorization tracking: Store the insurer’s pre-authorization as a case and attach it when booking. The authorization code then follows the appointment through to the claim
  4. Claim check: Open the claim pre-filled from the invoice and validate it. It carries J1300, the ICD-10 code, the authorization reference and any separately billed guidance code
  5. Submission through Healthcode: Pabau sends private medical insurance claims through Healthcode, the UK’s electronic billing clearinghouse, to Bupa, AXA Health, Vitality and other insurers
  6. Tracking: The claims dashboard follows every claim from Pending to Paid and flags any claim that needs action

Practitioners moving from the NHS into private work meet pre-authorization and insurer invoicing for the first time. Setting up CCSD billing early prevents the ad hoc invoicing behind most claim errors.

Pabau insurer payment matching screen listing AXA and Bupa invoices with paid, unpaid and reissued statuses
Pabau matches each insurer remittance to its invoices, so an unpaid or underpaid J1300 claim from Bupa or AXA Health stands out quickly.

Streamline your CCSD billing workflows

Pabau helps UK private practices manage CCSD claims, pre-authorization tracking and insurer invoicing in one place. See how it handles J1300 and the rest of your procedure fee schedule.

Pabau practice management software for UK private practices

Conclusion

J1300 is a narrow code, and that narrowness makes it easy to bill well. Put the needle work under J1300, and give guidance, pathology and the consultation their own lines.

Most of the revenue risk sits before the needle goes in. Get the pre-authorization number at booking, pick the most specific ICD-10 code, and finish the procedure note before discharge. Those three habits prevent the most common J1300 denials.

Want J1300 claims that reach the insurer complete the first time? Book a demo to see how Pabau tracks pre-authorizations and sends claims through Healthcode.

Continue your research

Continue your research

Managing the full CCSD billing cycle? Bupa CCSD codes and fee schedule covers how Bupa procedure codes are structured and submitted through private practice billing systems.

Moving from biopsy to surgery? CCSD code J0310 covers billing a liver tumor resection once the biopsy confirms the diagnosis.

Billing the same procedure in the US? CPT code 47000 explains how a percutaneous needle biopsy of the liver is coded under CPT.

Taking tissue through the gut wall instead? CCSD code J6730 covers endoscopic upper GI ultrasound, including transmucosal biopsy.

Frequently asked questions

What does CCSD code J1300 cover?

CCSD code J1300 covers percutaneous biopsy of lesion of liver: A needle biopsy of a focal liver lesion through the skin. It’s usually done under ultrasound or CT guidance. Histopathology is always billed separately. Imaging guidance is billed separately where the insurer doesn’t bundle it into the J1300 fee.

Does J1300 include imaging guidance, or is that coded separately?

Imaging guidance is usually coded separately, under a CCSD radiology code, but some payers bundle it into the J1300 fee. Check each insurer’s current provider handbook before adding a guidance code to the claim.

Which PMI payers require pre-authorization for J1300?

Bupa, AXA Health, Aviva and Vitality Health all typically require pre-authorization before a percutaneous liver biopsy. A J1300 claim without a valid authorization number is the most common cause of first-pass denial. Confirm the requirement in each payer’s current provider handbook, because policies are reviewed regularly.

Can J1300 be billed alongside a histopathology code for the specimen?

Yes. The pathology lab bills histopathology of the biopsy specimen separately, under the appropriate pathology CCSD code. The two codes cover distinct services and aren’t bundled. J1300 covers the procedure, and the histopathology code covers the lab analysis.

What is the difference between J1300 and a surgical liver biopsy code?

J1300 covers the percutaneous approach only: A needle biopsy through the skin, without surgical access. An open liver biopsy, where the abdomen is surgically opened, is billed under another CCSD code in the abdomen chapter. A laparoscopic biopsy through a port has its own code too. The approach, not the indication, decides which code applies.

What ICD-10 diagnosis codes support medical necessity for J1300?

For a suspected tumor, the usual codes are R93.2 for abnormal liver imaging, C22.0 or C22.9 for primary liver cancer, and C78.7 for metastases. For chronic liver disease, K74.6 (cirrhosis), K76.0 (NAFLD) and B18.2 (chronic hepatitis C) are common. More specific codes support claims better than unspecified ones.

Avatar photo
Maja Popovska
Content Writer

Maja is a Senior Content Writer at Pabau, where she covers everything from practice management and compliance to medical aesthetics and patient experience. Off the clock: binging true crime docuseries, baking and dreaming about travel.
×